Skip to main content
. 2024 Dec 14;11:20499361241304516. doi: 10.1177/20499361241304516

Table 4.

The area under the ROC curve and cut-off points of conventional and molecular tests compared to Xpert MTB/RIF Ultra.

Variable AUC/ROC (CI 95%) Sensibility Especificity LHR+ LHR− VPP VPN Prevalence
All samples
 Smear 0.685 (0.592–0.777) 37.04 100.0 0.629 100.0 85.30 21.0
 Mycobacteria culture 0.697 (0.628–0.767) 39.58 100.0 0.604 100.0 81.40 27.0
 Cobas MTB 0.954 (0.914–0.994) 91.67 99.21 116.4 0.084 97.80 96.90 27.0
 Logix Smart MTB 0.896 (0.835–0.957) 80.95 98.31 47.76 0.193 94.40 93.50 26.0
Pulmonary samples
 Smear 0.700 (0.602–0.798) 40.00 100.0 0.600 100.0 81.30 28.0
 Mycobacteria culture 0.726 (0.650–0.802) 45.24 100.0 0.547 100.0 78.50 33.0
 Cobas MTB 0.964 (0.924–0.999) 92.86 100.0 0.071 100.0 96.60 33.0
 Logix Smart MTB 0.891 (0.824–0.959) 78.38 100.0 0.216 100.0 90.80 32.0
Extrapulmonary samples
 Smear
 Mycobacteria culture
 Cobas MTB 0.905 (0.740–0.999) 83.33 97.67 35.83 0.170 83.30 97.70 12.0
 Logix Smart MTB 0.974 (0.939–0.999) 100.0 94.87 19.5 0.000 100.0 100.0 16.0

AUC, area under the curve; MTB, Mycobacterium tuberculosis; ROC, receiver operating characteristic; LHR, Likelihood ratio; 95% CI, 95% confidence interval.